Michelle Piquet
Michelle Piquet has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- David A. Ruddy
Novartis Biomedical Research, Oncology
49 shared publications - Jeffrey A. Engelman
Mass. General Hospital Cancer Center, Charlestown, MA
40 shared publications - Joel P. Wagner
Novartis Biomedical Research, Oncology
40 shared publications - Markus Riester
Novartis Institutes for BioMedical Research Incorporation, Massachusetts, 02139, USA
40 shared publications - Vivek Sagar
Oncology Data Science, Novartis Biomedical Research, Cambridge, Massachusetts
40 shared publications - Angelo L. Grauel
Novartis Institutes for Biomedical Research 5 Cambridge
37 shared publications
Latest Publications
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Tables and Figures from Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses
Supplementary tables S1-S5 and figures S1-S7
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables and Figures from Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses
Supplementary tables S1-S5 and figures S1-S7
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S5 shows distribution of barcoded clones into Louvain clusters.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S5 shows distribution of barcoded clones into Louvain clusters.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S7 shows clone family gene signature set expression at drug tolerance.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S7 shows clone family gene signature set expression at drug tolerance.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S8 shows clone family contribution at drug resistance and sensitivity to drug combinations.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S8 shows clone family contribution at drug resistance and sensitivity to drug combinations.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S1 shows barcode enrichment in drug treated cells, copy number segmentation, and xBC library cloning.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S1 shows barcode enrichment in drug treated cells, copy number segmentation, and xBC library cloning.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S3 shows Louvain clusters overlaid onto UMAP plots and contribution of cells by time point.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S3 shows Louvain clusters overlaid onto UMAP plots and contribution of cells by time point.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S6 shows clone family UMAPs, proportion change in response to drug, and gene signature set expression at untreated and acute drug treatment.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S6 shows clone family UMAPs, proportion change in response to drug, and gene signature set expression at untreated and acute drug treatment.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure and Table Legends from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Legends for Supplemental Figures and Tables
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure and Table Legends from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Legends for Supplemental Figures and Tables
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S4 shows abundance of individual barcoded clones.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S4 shows abundance of individual barcoded clones.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S2 shows UMAP plots, entropy analysis, quantification of barcode abundance, cell sensitivity to drug, and average gene signature set expression in sensitive vs tolerant clones.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Supplemental Figure S2 shows UMAP plots, entropy analysis, quantification of barcode abundance, cell sensitivity to drug, and average gene signature set expression in sensitive vs tolerant clones.